Travers Smith is advising EMIS Group plc on its recommended £1.243bn takeover offer by Bordeaux UK Holdings II Limited, an affiliate of Optum Health Solutions (UK) Limited and a wholly owned subsidiary of UnitedHealth Group Incorporated.
Listed on the London Stock Exchange AIM market since 2010, EMIS has grown to become a UK leader in connected healthcare software and systems. Its solutions are widely used across a number of major UK healthcare settings, most notably primary care, community care, accident and emergency, and community and hospital pharmacies.
The Travers Smith team is led by Corporate Partner Richard Spedding, supported by Senior Associate Ben Lowen, Associate China Waters and Trainee Haroon Zaman. The team also included: merger control/NSIA support from partner Stephen Whitfield, Senior Associate Ingrid Rogers and Associate Chloe Budd; and Incentives & Remuneration support from Senior Counsel Elissavet Grout and associate Tom Leatherby.